379 related articles for article (PubMed ID: 2976059)
1. Cervical cancer risk and use of depot-medroxyprogesterone acetate in Costa Rica.
Oberle MW; Rosero-Bixby L; Irwin KL; Fortney JA; Lee NC; Whatley AS; Bonhomme MG
Int J Epidemiol; 1988 Dec; 17(4):718-23. PubMed ID: 2976059
[TBL] [Abstract][Full Text] [Related]
2. A case-control study of breast cancer and hormonal contraception in Costa Rica.
Lee NC; Rosero-Bixby L; Oberle MW; Grimaldo C; Whatley AS; Rovira EZ
J Natl Cancer Inst; 1987 Dec; 79(6):1247-54. PubMed ID: 2961909
[TBL] [Abstract][Full Text] [Related]
3. Depot-medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasia.
La Vecchia C
Contraception; 1994 Mar; 49(3):223-30. PubMed ID: 8200216
[TBL] [Abstract][Full Text] [Related]
4. Invasive cervical cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Thomas DB; Noonan L; Whitehead A; Roseman D
Bull World Health Organ; 1985; 63(3):505-11. PubMed ID: 2931205
[TBL] [Abstract][Full Text] [Related]
5. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
[TBL] [Abstract][Full Text] [Related]
6. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Contraception; 1992 Apr; 45(4):299-312. PubMed ID: 1387601
[TBL] [Abstract][Full Text] [Related]
7. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
Orr-Walker BJ; Evans MC; Ames RW; Clearwater JM; Cundy T; Reid IR
Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
[TBL] [Abstract][Full Text] [Related]
8. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
Kaunitz AM
J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
[TBL] [Abstract][Full Text] [Related]
9. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
Paiva LC; Pinto-Neto AM; Faundes A
Contraception; 1998 Dec; 58(6):351-5. PubMed ID: 10095971
[TBL] [Abstract][Full Text] [Related]
10. Hospitalizations among black women using contraceptives.
Higgins JE; Wilkens LR; Chi IC; Hatcher RA
Am J Obstet Gynecol; 1985 Oct; 153(3):280-7. PubMed ID: 2931987
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of depot-medroxyprogesterone acetate on lipoprotein metabolism.
Garza-Flores J; De la Cruz DL; Valles de Bourges V; Sanchez-Nuncio R; Martinez M; Fuziwara JL; Pérez-Palacios G
Contraception; 1991 Jul; 44(1):61-71. PubMed ID: 1832626
[TBL] [Abstract][Full Text] [Related]
12. Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Thomas DB; Ye Z; Ray RM
Contraception; 1995 Jan; 51(1):25-31. PubMed ID: 7750280
[TBL] [Abstract][Full Text] [Related]
13. Depot medroxyprogesterone acetate and breast cancer. A review of current knowledge.
Chilvers CE
Drug Saf; 1996 Sep; 15(3):212-8. PubMed ID: 8879975
[TBL] [Abstract][Full Text] [Related]
14. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA
JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Thomas DB; Noonan L; Whitehead A
Bull World Health Organ; 1985; 63(3):513-9. PubMed ID: 2931206
[TBL] [Abstract][Full Text] [Related]
16. Bone density in long term users of depot medroxyprogesterone acetate.
Gbolade B; Ellis S; Murby B; Randall S; Kirkman R
Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association?
Irwin KL; Rosero-Bixby L; Oberle MW; Lee NC; Whatley AS; Fortney JA; Bonhomme MG
JAMA; 1988 Jan; 259(1):59-64. PubMed ID: 3334773
[TBL] [Abstract][Full Text] [Related]
18. Depo medroxyprogesterone acetate (DMPA) and combined oral contraceptives and cervical carcinoma in-situ in women aged 50 years and under.
Hoyo C; Cousins DS; Bisgrove EZ; Gaines MM; Schwingl PJ; Fortney JA
West Indian Med J; 2004 Dec; 53(6):406-12. PubMed ID: 15816269
[TBL] [Abstract][Full Text] [Related]
19. Trabecular bone in long-term depot-medroxyprogesterone acetate users.
Virutamasen P; Wangsuphachart S; Reinprayoon D; Kriengsinyot R; Leepipatpaiboon S; Gua C
Asia Oceania J Obstet Gynaecol; 1994 Sep; 20(3):269-74. PubMed ID: 7811192
[TBL] [Abstract][Full Text] [Related]
20. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Thomas DB; Ray RM
Contraception; 1995 Nov; 52(5):307-12. PubMed ID: 8585888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
